Loading...
XNAS
RKDA
Market cap423kUSD
Oct 08, Last price  
0.27USD
1D
-4.67%
1Q
-60.05%
Jan 2017
-99.96%
IPO
-100.00%
Name

Arcadia Biosciences Inc

Chart & performance

D1W1MN
XNAS:RKDA chart
P/E
—
P/S
0.09
EPS
—
Div yield, %
—
Shrs. gr., 5y
40.60%
Rev. gr., 5y
-9.57%
Revenues
5m
-3.71%
7,010,0006,478,0006,982,0005,414,0003,188,0004,026,0001,464,0001,169,0008,034,0006,780,0007,418,0004,454,0005,045,0004,858,000
Net income
-2m
L-66.77%
-12,370,000-13,195,000-18,339,000-17,956,000-19,624,000-15,707,000-13,480,000-28,805,000-4,655,000-14,660,000-15,376,000-13,981,000-7,038,000-2,339,000
CFO
-5m
L-50.77%
-9,588,000-9,745,000-14,787,000-15,109,000-17,055,000-13,965,000-13,631,000-17,198,000-30,218,000-25,868,000-13,977,000-15,294,000-9,627,000-4,739,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California.

Key people

Matthew T. Plavan
Chief Executive Officer, Director · since 2019
Pamela Haley
Chief Financial Officer · since 2019
Donald L Emlay
Vice President - Regulatory Affairs and Compliance · since 2004
Zhongjin Lu
Director - Product Development · since 2018
Sarah Reiter
Chief Commercial Officer · since 2018
Jamie Bechtel
Director · since 2018
Albert D. Bolles
Director · since 2018
Peter Gajdos
Director · since 2014
Lilian Shackleford Murray
Director · since 2018
Gregory D. Waller
Director · since 2017
Amy J. Yoder
Director · since 2017
Uday Garg
Independent Director · since 2014
URL
https://arcadiabio.com/
IPO date
May 15, 2015
Employees
30
Domiciled in
US
Incorporated in
US
Headquarters & legal address
c/o THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT